Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Tango Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 89 | 100 | +11 |
| Shares | 68.3M | 88.8M | +20.5M (+30.0%) |
| Value | $226.8M | $999.9M | +$773.0M (+340.8%) |
New holders (22)
Institutions that held Tango Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (11)
Institutions that held Tango Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 309,572 | $1.03M |
| Citadel Advisors LLC | 164,986 | $547.8K |
| Man Group plc | 83,473 | $277.1K |
| Alyeska Investment Group, L.P. | 74,338 | $246.8K |
| Squarepoint Ops LLC | 40,316 | $133.8K |
| Algert Global LLC | 40,088 | $133.1K |
| Public Employees Retirement System of Ohio | 24,124 | $80.0K |
| Jane Street Group, LLC | 20,592 | $68.4K |
| PDT Partners, LLC | 13,989 | $46.4K |
| Two Sigma Securities, LLC | 12,069 | $40.1K |
| Two Sigma Advisers, LP | 10,100 | $33.5K |